Literature DB >> 3764439

Plasmacytomas in mice.

M Potter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3764439

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  6 in total

1.  Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia.

Authors:  N Swaminathan; G Lopez-Berestein; S Rudikoff
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation.

Authors:  D R Lewis; L M Pottern; L M Brown; D T Silverman; R B Hayes; J B Schoenberg; R S Greenberg; G M Swanson; A G Schwartz; J M Liff
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

3.  An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis.

Authors:  J Troppmair; M Potter; J S Wax; U R Rapp
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations.

Authors:  J Radl; Y A Punt; M H van den Enden-Vieveen; P A Bentvelzen; M H Bakkus; T W van den Akker; R Benner
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

5.  Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies.

Authors:  Kaini Shen; Gufeng Xu; Qing Wu; Daobin Zhou; Jian Li
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

Review 6.  The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.

Authors:  Liesbeth Bieghs; Hans E Johnsen; Ken Maes; Eline Menu; Els Van Valckenborgh; Michael T Overgaard; Mette Nyegaard; Cheryl A Conover; Karin Vanderkerken; Elke De Bruyne
Journal:  Oncotarget       Date:  2016-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.